Big Move For AIM ImmunoTech Inc.

AIM ImmunoTech Inc. (AIM:NYSEMKT) soared at $1.25, representing a gain of 58.2%. On Fri, Feb 13, 2026, AIM:NYSEMKT touched a New 2-Week High of $1.25. The stock appeared on our News Catalysts scanner on Thu, Feb 12, 2026 at 09:45 AM in the 'MISCELLANEOUS' category. From Fri, Jan 30, 2026, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Thu, Feb 05, 2026 at $1.88 with a volume of 68M+.

About AIM ImmunoTech Inc. (AIM:NYSEMKT)

AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.